Evaluation of the patient with unexplained stroke

Coronary Artery Disease

Volumn 19, Issue 7, 2008, Pages 535-540

  Kizer, Jorge R ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Aortic atheroma; Atrial septal anerusym; Echocardiography; Embolism; Patent foramen ovale; Stroke

Indexed keywords

ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EMBOLISM; HUMAN; IMAGE ANALYSIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

BRAIN ISCHEMIA; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STROKE;

EID: 55749107633     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32830eabb6     Document Type: Review

References (44)

1. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349:1498-1504.
2. Rosamond W, Regal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117:e25-e46.
3. Sacco RL, Ellenberg JH, Mohr JR Tatemichi TK, Hier DB, Price TR, Wolf PA. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989; 25:382-390. This article reports the prevalence and characteristics of infarcts of undetermined cause in a large multi-center registry. Although evaluation did not involve magnetic resonance imaging or transesophageal echocardiography, the large proportion of strokes of uncertain etiology, 40%, highlights the scope of cryptogenic embolism in the etiology of brain ischemia.
4. Albers GW, Amarenco P, Easton JD, Sacco RL, Teat P. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:630S-669S. Evidence-based guidelines from a professional society regarding ischemic stroke therapy. These guidelines specifically address individual cardiac and aortic sources of embolism.
5. Timsit SG, Sacco RL, Mohr JP, Foulkes MA, Tatemichi TK, Wolf PA, et al. Brain infarction severity differs according to cardiac or arterial embolic source. Neurology 1993; 43:728-733.
6. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 2001; 32:2559-2566.
7. Mohr JP, Albers GW, Amarenco P, Babikian VL, Biller J, Brey RL, et al. American Heart Association Prevention Conference. IV. Prevention and rehabilitation of stroke, etiology of stroke. Stroke 1997; 28:1501-1506.
8. Ay H, Oliveira-Filho J, Buonanno FS, Ezzeddine M, Schaefer PW, Rordorf G, et al. Diffusion-weighted imaging identifies a subset of lacunar infarction associated with embolic source. Stroke 1999; 30:2644-2650.
9. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993; 24:35-41. This article describes criteria for a commonly used classification scheme for ischemic stroke based on etiology.
10. Leys D, Bandu L, Henon H, Lucas C, Mounier-Vehier F, Rondepierre P, Godefroy O. Clinical outcome in 287 consecutive young adults (15-45 years) with ischemic stroke. Neurology 2002; 59:26-33. This report highlights the high prevalence of stroke of undetermined etiology in young adults despite use of transesophageal echocardiography and modern neuroimaging techniques.
11. Okada Y, Yamaguchi T, Minematsu K, Miyashita T, Sawada T, Sadoshima S, et al. Hemorrhagic transformation in cerebral embolism. Stroke 1989; 20:598-603.
12. Mohr JP. Cryptogenic stroke. N Engl J Med 1988; 318:1197-1198.
13. Barr JD. Cerebral angiography in the assessment of acute cerebral ischemia: guidelines and recommendations. J Vasc Interv Radiol 2004; 15 (1 Pt 2):S57-S66.
14. Kohl G. The evolution and state-of-the-art principles of multislice computed tomography. Proc Am Thorac Soc 2005; 2: 470-476, 499-500.
15. Wasserman BA, Wityk RJ, Trout HH 3rd, Virmani R. Low-grade carotid stenosis: looking beyond the lumen with MRI. Stroke 2005; 36:2504-2513. This review discusses the limitations of vascular imaging techniques based on evaluation of vessel lumen in view of arterial remodeling associated with atheromatous plaque deposition. It points to the potential of magnetic resonance imaging to evaluate for high-risk atheromatous plaque and identify the atherothromboembolic culprit.
16. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. W Engl J Med 1987; 316:1371-1375.
17. O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Woffson SK Jr, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke 1992; 23:1752-1760.
18. Meissner I, Khandheria BK, Sheps SG, Schwartz GL, Wiebers DO, Whisnant JP, et al. Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? A prospective population-based transesophageal echocardiography study. J Am Coll Cardiol 2004; 44:1018-1024.
19. Schwartz CJ, Mitchell JR. Atheroma of the carotid and vertebral arterial systems. Br Med J 1961; 2:1057-1063.
20. Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994; 331:1474-1479.
21. Kistler JP. Cerebral embolism. Compr Ther 1996; 22:515-530.
22. Overell JR, Bone I, Less KR. Interatrial septal abnormalities and stroke. A meta-analysis of case-control studies. Neurology 2000; 55:1172-1179. Systematic review of case-control studies of interatrial septal abnormalities showing an important association between patent foramen ovale and atrial septal aneurysm and stroke in patients under 55 years of age, but not older.
23. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007; 357:2262-2268.
24. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345:1740-1746. Largest prospective observational study of interatrial septal abnormalities in young patients with cryptogenic stroke, and represents a major contribution to the literature. The study found an increased risk of recurrent stroke for the combination of patent foramen ovale and atrial septal aneurysm, but not of patent foramen ovale alone, compared to the absence of interatrial septal abnormalities for patients receiving aspirin.
25. Kizer JR, Devereux RB. Clinical practice. Patent foramen ovale in young adults with unexplained stroke. N Engl J Med 2005; 353:2361-2372. Evidence-based review of the relationship between patent foramen ovale and ischemic stroke in young adults, detailing controversies regarding pathogenetic role and optimal diagnosis and management. The article reviews guidelines from professional societies, underscores the need for prospective studies, and offers provisional recommendations for evaluation and management.
26. Kizer JR, Silvestry FE, Kimmel SE, Kasner SE, Wiegers SE, Erwin MB, et al. Racial differences in the prevalence of cardiac sources of embolism in subjects with unexplained stroke or transient ischemic attack evaluated by transesophageal echocardiography. Am J Cardiol 2002; 90:395-400.
27. Doufekias E, Segal AZ, Kizer JR. Cardiogenic and aortogenic brain embolism. J Am Coll Cardiol 2008; 51:1049-1059. Evidenced-based review of diagnosis, prognosis and treatment of stroke of cardiac and aortic origin, highlighting recommendations from professional societies.
28. Liao J, Khalid Z, Scallan C, Morillo C, O'Donnell M. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke 2007; 38:2935-2940. Systematic review documenting the utility of Holler monitoring for enhanced detection of atrial dysrhythmias post-stroke.
29. Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 2004; 35:1647-1651.
30. Wallmann D, Tuller D, Wustmann K, Meier P, Isenegger J, Arnold M, et al. Frequent atrial premature beats predict paroxysmal atrial fibrillation in stroke patients: an opportunity for a new diagnostic strategy. Stroke 2007; 38:2292-2294.
31. Cheitlin MD, Armstrong WF, Aurigemma GP, Seller GA, Bierman FZ, Davis JL, et al. ACC/AHA/ASE 2003 Guideline update for the clinical application of echocardiography. Circulation 2003; 108:1146-1162.
32. Rahmatullah AF, Rahko PS, Stein JH. Transesphageal echocardography for the evaluation and management of patients with cerebral ischemia. Clin Cardiol 1999; 22:391-396. This review discusses the advantages of transesophageal echocardiography relative to transthoracic echocardiogrpahy in the detection of potential cardiac sources of embolism in patients with brain ischemia.
33. Manning WJ. Role of transesophageal echocardiography in the management of thromboembolic stroke. Am J Cardiol 1997; 80:19D-28D.
34. Di Tullio MR, Sacco RL, Venketasubramanian N, Sherman D, Mohr JP, Homma S. Comparison of diagnostic techniques for the detection of patent foramen ovale in stroke patients. Stroke 1993; 24:1020-1024.
35. Mugge A, Daniel W, Angermann C, Spes C, Khandheria BK, Kronzon I, et al. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995; 91:2785-2792.
36. Ha JW, Shin MS, Kang S, Pyun WB, Jang KJ, Byun KH, et al. Enhanced detection of right-to-left shunt through patent foramen ovale by transthoracic echocardiography using harmonic imaging. Am J Cardiol 2001; 87:669-671.
37. Souteyrand G, Motreff P, Lusson JR, Rodriguez R, Geoffroy E, Dauphin C, et al. Comparison of transthoracic echocardiography using second harmonic imaging, transcranial Doppler and transesophageal echocardiography for the detection of patent foramen ovale in stroke patients. Eur J Echocardiogr 2006; 7:147-154.
38. Kerr AJ, Buck T, Chia K, Chow CM, Fox E, Levine RA, Picard MH. Transmitral Doppler: a new transthoracic contrast method for patent foramen ovale detection and quantification. J Am Coll Cardiol 2000; 36:1959-1966. This study describes a new contrast technique for the detection of right-to-left shunts by transthoracic echocardiography using transmitral Doppler imaging. The diagnostic accuracy of this method proved to be comparable to transesophageal echocardiography, but the results require independent confirmation.
39. Sloan MA, Alexandrov AV, Tegeler CH, Spencer MP, Caplan LR, Feldmann E, et al. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2004; 62:1468-1481. Professional society statement on the advantages and limitations of transcranial Doppler ultrasonography and its applications, including assessment of right-to-left shunts.
40. Harloff A, Handke M, Reinhard M, Geibel A, Hetzel A. Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke. Stroke 2006; 37:859-864.
41. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 2006; 113:e409-e449. Evidence-based professional guidelines for the management of patients with cerebral ischemia, including specific cardiac sources of embolism.
42. Cramer SC, Rordorf G, Kaufman JA, Buonanno F, Koroshetz WJ, Schwamm L. Clinically occult pelvic-vein thrombosis in cryptogenic stroke. Lancet 1998; 351:1927-1928.
43. Moussouttas M, Fayad P, Rosenblatt M, Hashmolo M, Pollak J, Henderson K, et al. Pulmonary arteriovenous malformations. Cerebral ischemia and neurologic manifestations. Neurology 2000; 55:959-964.
44. Rolfs A, Bottcher T, Zschiesche M, Morris P, Winchester B, Bauer P, et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 2005; 366:1794-1796.